Mirae Asset Healthcare Fund Regular Growth
- Sector - Healthcare
- Equity
- Very High Risk
Rating:
Key Metrics
Aum
₹3,252.55 Cr
Expense Ratio
1.66%
Exit Load
1.00%
Min. Investment
₹5,000.00
Min. SIP
₹99.00
Launch Date
2 Jun 2018
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +3.03% | -- |
| 3 Months | +9.21% | -- |
| 6 Months | +21.88% | -- |
| 1 Year | +21.35% | +21.35% |
| 2 Years | -- | +11.3% |
| 3 Years | +77.49% | +21.08% |
| 5 Years | +95.18% | +14.31% |
| Since Launch | +356.59% | +20.38% |
Holdings as on 11 Aug 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 356.13 | 10.95 |
| Divi's Laboratories | 244.86 | 7.53 |
| JB Chemicals & Pharmaceuticals Ltd | 211.08 | 6.49 |
| Apollo Hospitals Enterprise | 198.21 | 6.09 |
| Glenmark Pharmaceuticals | 198.04 | 6.09 |
| Laurus Labs | 149.89 | 4.61 |
| Dr Reddy's Laboratories | 140.89 | 4.33 |
| Aurobindo Pharma | 140.88 | 4.33 |
| Lupin | 134.30 | 4.13 |
| Krishna Institute of Medical Sciences Ltd | 125.18 | 3.85 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.93
Sharpe Ratio
16.11%
Std. Deviation
4.63%
Tracking Error
9.10%
Alpha
0.92
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Growth | +24.02% | +23.07% | +17.36% |
| Mirae Asset Healthcare Fund Regular Growth | +21.35% | +21.08% | +14.31% |
| DSP Healthcare Fund Regular Growth | +15.16% | +19.37% | +14.49% |
| Tata India Pharma & Healthcare Fund Regular Growth | +13.24% | +18.38% | +13.68% |
| HDFC Pharma and Healthcare Fund Regular Growth | +27.38% | -- | -- |
Results are calculated on CAGR basis
About Fund
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.
The Mirae Asset Healthcare Fund Regular Growth has an AUM of 3252.55 crores & has delivered CAGR of 14.31 in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.66%. The minimum investment in Mirae Asset Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 99.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, JB Chemicals & Pharmaceuticals Ltd, Apollo Hospitals Enterprise.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs, Chemical Manufacturing.
Some of the similar funds are SBI Healthcare Opportunities Fund Regular Growth, Mirae Asset Healthcare Fund Regular Growth, DSP Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Mirae Asset Healthcare Fund Regular Growth has a sharpe ratio of 0.93 & a standard deviation of 16.11%.
FAQs
According to the morning star rating Mirae Asset Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
Mirae Asset Healthcare Fund Regular Growth is managed by Vrijesh Kasera,Tanmay Mehta.
The expense ratio of Mirae Asset Healthcare Fund Regular Growth is 1.66%.
The 5 year annualized return on Mirae Asset Healthcare Fund Regular Growth is 14.31% & it has generated 21.35% in the last 1 year.
The minimum investment in Mirae Asset Healthcare Fund Regular Growth is 5000 Rs.
Mirae Asset Healthcare Fund Regular Growth has an AUM of 3252.55 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.